Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90-Reference-Cited by-同舟云学术

Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90

Published:2005-12-24 Issue:2 Volume:49 Page:817-828
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Biamonte Marco A.¹,Shi Jiandong¹,Hong Kevin¹,Hurst David C.¹,Zhang Lin¹,Fan Junhua¹,Busch David J.¹,Karjian Patricia L.¹,Maldonado Angelica A.¹,Sensintaffar John L.¹,Yang Yong-Ching¹,Kamal Adeela¹,Lough Rachel E.¹,Lundgren Karen¹,Burrows Francis J.¹,Timony Gregg A.¹,Boehm Marcus F.¹,Kasibhatla Srinivas R.¹

Affiliation:

1. Conforma Therapeutics Corporation, 9393 Towne Centre Drive, Suite 240, San Diego, California 92121

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0503087

Reference30 articles.

1. BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90

2. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

3. Altered states: selectively drugging the Hsp90 cancer chaperone

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments towards the Synthesis of Pyrimidopyrimidine and Purine Derivatives;ChemistrySelect;2023-07-10

2. Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances;European Journal of Medicinal Chemistry;2022-08

3. Hsp90 Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance;European Journal of Medicinal Chemistry;2021-01

5. C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action;Bioorganic & Medicinal Chemistry;2019-11